ArticleAdvanced healthcare materials2026
Sprayable Polymer Blends With Short-Chain Surface Segregation for Preventing Postoperative Abdominal Adhesions.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Adhesions are common post-surgical complications where fibrous tissue bridges adjacent surfaces following tissue injury. Although Seprafilm is a widely used clinical prophylactic, it often proves inadequate due to suboptimal mechanical stability and applicability. Solution Blow Spinning (SBS) enables the formation of polymer fibers tailored to complex geometries with excellent tissue adherence. Poly(D,L-lactide-co-caprolactone) (PLCL) polymer has shown promise as an adhesions barrier but remains inconsistent because of its inherent tackiness and hydrophobicity. Here, high molecular weight (HMW) PLCL (40 or 80 kDa) was blended with low molecular weight (LMW) polyethylene glycol (PEG, 1 or 3 kDa). In vitro studies confirmed that PLCL/PEG fibers achieved tissue adhesion strengths above 10 kPa and sustained mechanical performance throughout clinically relevant degradation timelines. Blending PEG changes the surface composition of the spray-deposited mats, substantially improving the hydrophilic character and lowering protein adherence in vitro. In a murine cecal ligation model, the PLCL/PEG blends demonstrated significantly reduced adhesion severity and incidence compared to both untreated and Seprafilm-treated controls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.